Detalhe da pesquisa
1.
Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.
Biomed Res Int
; 2014: 209670, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24987674
2.
Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.
Clin Lymphoma Myeloma Leuk
; 13(2): 123-30, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23291040